Giles Platford is President of the Plasma-Derived Therapies Business Unit at Takeda Pharmaceutical Company Ltd.
Mr. Platford joined Takeda in 2009 as General Manager of Brazil, after which he assumed the role of Area Head for Middle East, Turkey & Africa, before then joining Takeda Executive Team in 2014 as President of Emerging Markets. In 2017 he took up his most recent role as President of Europe & Canada, where he also represented Takeda as a board member of the European Federation of Pharmaceutical Industries and Associations (EFPIA).
Mr. Platford is the current Global Chair of the Board for the Plasma Protein Therapeutics Association, which represents the private sector manufacturers of plasma protein therapies.
Prior to joining Takeda, Mr. Platford spent eight years in Asia Pacific, where he held a number of roles of increasing responsibility in Business Development, Commercial and General Management.
Mr. Platford holds a Bachelor of Arts degree in business and marketing management from Oxford Brookes University, UK, and is currently based in Boston, USA.